335 related articles for article (PubMed ID: 26888559)
1. Emerging importance of chemokine receptor CXCR3 and its ligands in cardiovascular diseases.
Altara R; Manca M; Brandão RD; Zeidan A; Booz GW; Zouein FA
Clin Sci (Lond); 2016 Apr; 130(7):463-78. PubMed ID: 26888559
[TBL] [Abstract][Full Text] [Related]
2. CXCR3 ligands in disease and therapy.
Van Raemdonck K; Van den Steen PE; Liekens S; Van Damme J; Struyf S
Cytokine Growth Factor Rev; 2015 Jun; 26(3):311-27. PubMed ID: 25498524
[TBL] [Abstract][Full Text] [Related]
3. CXCR3, a double-edged sword in tumor progression and angiogenesis.
Billottet C; Quemener C; Bikfalvi A
Biochim Biophys Acta; 2013 Dec; 1836(2):287-95. PubMed ID: 23994549
[TBL] [Abstract][Full Text] [Related]
4. The Distinct Roles of CXCR3 Variants and Their Ligands in the Tumor Microenvironment.
Reynders N; Abboud D; Baragli A; Noman MZ; Rogister B; Niclou SP; Heveker N; Janji B; Hanson J; Szpakowska M; Chevigné A
Cells; 2019 Jun; 8(6):. PubMed ID: 31216755
[TBL] [Abstract][Full Text] [Related]
5. Elevated serum levels of the CXCR3 chemokine ITAC are associated with the development of transplant coronary artery disease.
Kao J; Kobashigawa J; Fishbein MC; MacLellan WR; Burdick MD; Belperio JA; Strieter RM
Circulation; 2003 Apr; 107(15):1958-61. PubMed ID: 12695288
[TBL] [Abstract][Full Text] [Related]
6. The CXCL10/CXCR3 Axis and Cardiac Inflammation: Implications for Immunotherapy to Treat Infectious and Noninfectious Diseases of the Heart.
Altara R; Mallat Z; Booz GW; Zouein FA
J Immunol Res; 2016; 2016():4396368. PubMed ID: 27795961
[TBL] [Abstract][Full Text] [Related]
7. The Role of Chemokine Receptor CXCR3 and Its Ligands in Renal Cell Carcinoma.
Gudowska-Sawczuk M; Kudelski J; Mroczko B
Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33202536
[TBL] [Abstract][Full Text] [Related]
8. The Role of CXCR3 and Associated Chemokines in the Development of Atherosclerosis and During Myocardial Infarction.
Szentes V; Gazdag M; Szokodi I; Dézsi CA
Front Immunol; 2018; 9():1932. PubMed ID: 30210493
[TBL] [Abstract][Full Text] [Related]
9. Serum chemokine receptor CXCR3 ligands are associated with progression, organ dysfunction and complications of chronic liver diseases.
Tacke F; Zimmermann HW; Berres ML; Trautwein C; Wasmuth HE
Liver Int; 2011 Jul; 31(6):840-9. PubMed ID: 21645215
[TBL] [Abstract][Full Text] [Related]
10. Activating transcription factor 3 in cardiovascular diseases: a potential therapeutic target.
Zhou H; Li N; Yuan Y; Jin YG; Guo H; Deng W; Tang QZ
Basic Res Cardiol; 2018 Aug; 113(5):37. PubMed ID: 30094473
[TBL] [Abstract][Full Text] [Related]
11. Up-regulation of the interferon gamma (IFN-gamma)-inducible chemokines IFN-inducible T-cell alpha chemoattractant and monokine induced by IFN-gamma and of their receptor CXC receptor 3 in human renal cell carcinoma.
Suyama T; Furuya M; Nishiyama M; Kasuya Y; Kimura S; Ichikawa T; Ueda T; Nikaido T; Ito H; Ishikura H
Cancer; 2005 Jan; 103(2):258-67. PubMed ID: 15578685
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological characterization of CXC chemokine receptor 3 ligands and a small molecule antagonist.
Heise CE; Pahuja A; Hudson SC; Mistry MS; Putnam AL; Gross MM; Gottlieb PA; Wade WS; Kiankarimi M; Schwarz D; Crowe P; Zlotnik A; Alleva DG
J Pharmacol Exp Ther; 2005 Jun; 313(3):1263-71. PubMed ID: 15761110
[TBL] [Abstract][Full Text] [Related]
13. An alternatively spliced variant of CXCR3 mediates the inhibition of endothelial cell growth induced by IP-10, Mig, and I-TAC, and acts as functional receptor for platelet factor 4.
Lasagni L; Francalanci M; Annunziato F; Lazzeri E; Giannini S; Cosmi L; Sagrinati C; Mazzinghi B; Orlando C; Maggi E; Marra F; Romagnani S; Serio M; Romagnani P
J Exp Med; 2003 Jun; 197(11):1537-49. PubMed ID: 12782716
[TBL] [Abstract][Full Text] [Related]
14. The role of CXCR3 and its ligands in renal transplant outcome.
Dabiri S; Kariminik A; Kennedy D
Eur Cytokine Netw; 2016 Jun; 27(2):34-40. PubMed ID: 27478077
[TBL] [Abstract][Full Text] [Related]
15. The transmembrane G protein-coupled CXCR3 receptor-ligand system and maternal foetal allograft rejection.
Amabebe E; Anumba DO
Placenta; 2021 Jan; 104():81-88. PubMed ID: 33296735
[TBL] [Abstract][Full Text] [Related]
16. CXCR3 ligands are augmented during the pathogenesis of pulmonary sarcoidosis.
Busuttil A; Weigt SS; Keane MP; Xue YY; Palchevskiy V; Burdick MD; Huang C; Zisman DA; Fishbein M; Lynch JP; Strieter RM; Elashoff RM; Belperio JA
Eur Respir J; 2009 Sep; 34(3):676-86. PubMed ID: 19386686
[TBL] [Abstract][Full Text] [Related]
17. Heparin displaces interferon-gamma-inducible chemokines (IP-10, I-TAC, and Mig) sequestered in the vasculature and inhibits the transendothelial migration and arterial recruitment of T cells.
Ranjbaran H; Wang Y; Manes TD; Yakimov AO; Akhtar S; Kluger MS; Pober JS; Tellides G
Circulation; 2006 Sep; 114(12):1293-300. PubMed ID: 16940188
[TBL] [Abstract][Full Text] [Related]
18. CCR3 functional responses are regulated by both CXCR3 and its ligands CXCL9, CXCL10 and CXCL11.
Xanthou G; Duchesnes CE; Williams TJ; Pease JE
Eur J Immunol; 2003 Aug; 33(8):2241-50. PubMed ID: 12884299
[TBL] [Abstract][Full Text] [Related]
19. Cardiovascular effects of sphingosine-1-phosphate (S1P).
Levkau B
Handb Exp Pharmacol; 2013; (216):147-70. PubMed ID: 23563656
[TBL] [Abstract][Full Text] [Related]
20. Human IP-9: A keratinocyte-derived high affinity CXC-chemokine ligand for the IP-10/Mig receptor (CXCR3).
Tensen CP; Flier J; Van Der Raaij-Helmer EM; Sampat-Sardjoepersad S; Van Der Schors RC; Leurs R; Scheper RJ; Boorsma DM; Willemze R
J Invest Dermatol; 1999 May; 112(5):716-22. PubMed ID: 10233762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
